Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.4 (trypsin)
 42,187 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The cortical thymocytes expressed at least three distinct cell-surface differentiation antigens. CD1a (Mr 49,000), CD1b (Mr 45,000) and CD1c (Mr 43,000) which are non-covalently attached to beta 2-microglobulin. In the present study, we confirm the presence of two out of the three CD1 molecules on epidermal Langerhans cells by biochemical analysis. Furthermore some CD1a monoclonal antibodies immunoprecipitated an additional molecule with an apparent relative mass of 27,000 from Langerhans cell-enriched epidermal cell lysates and not from fresh iodinated thymocyte lysates. From trypsin-treated thymocyte lysates, this low molecular weight protein was considered as a cleavage product of Mr 49,000 molecule (CD1a molecule) by this enzyme which is used to obtain epidermal cell suspensions. This Mr 27,000 was found to content one N-linked oligosaccharide residue by endoglycosidase F treatment. On CD1-expressing cells (thymocytes and Langerhans cells) it would be tempting to take advantage of the sensitivity of CD1a molecule to trypsin in order to precise the structure/function relationship of CD1a antigen.
 ...
PMID:The effect of trypsin on CD1a molecule of human thymocytes. 169 34

Human epidermal Langerhans cells express two (CD1a and CD1c) of the three human thymic cell surface differentiation antigens (CD1a, CD1b, and CD1c). The first cluster of differentiation antigens (CD1) is defined by a group of monoclonal antibodies (MCA). All these MCA were obtained after immunization of mice or rats with human cortical thymocytes. OKT6 MCA (a CD1a MCA) was the first to be described as reactive with human epidermal Langerhans cells. We produced a murine MCA, called DMC1, after immunization with proliferating Langerhans cells of Eosinophilic Granuloma of the bone (Histiocytosis X). In tissues DMC1 MCA reacted with epidermal dendritic cells (Langerhans cells) in the skin and cortical thymocytes in the thymus as observed on indirect immunofluorescence. At the ultrastructural level, DMC1 MCA was specific for Birbeck granule-containing Langerhans cells and did not react with melanocyte and keratinocyte populations. The quantitative analysis of immunoelectron labeling and the cytofluorometric study showed that the intensity of labeling was inversely correlated with the concentration of trypsin used in the preparation of epidermal cell from skin samples. DMC1 MCA precipitated a protein with a relative mass of 49,000 (CD1a molecule) from lysates of iodinated epidermal Langerhans cells under reducing conditions. It recognized the original CD1a molecule (Mr 49,000) but not the membrane breakdown product of CD1a (Mr 27,000) brought about by trypsin.
 ...
PMID:DMC1: a monoclonal antibody produced from histiocytosis X cells which reacts with the native CD1a molecule of human epidermal Langerhans cells. 246 37

The T-cell surface differentiation antigens expressed on cortical thymocytes are composed of 3 molecules, CD1a (Mr 49,000), CD1b (Mr 45,000), and CD1c (Mr 43,000), which are non-covalently attached to beta 2-microglobulin. In the present study, differences in quantitative binding (immunogold labelling) were observed with four CD1a monoclonal antibodies (mAb), Na1/34, L544, Vit6 and OKT6, on epidermal Langerhans cells obtained through trypsinization and Ficoll-Hypaque sedimentation. These cells were surface-labelled with 125I and then lysed. Immunoprecipitation was carried out with five CD1a mAb, BL6, 10D12.2, L404, L544 and OKT6, and immunoprecipitates were electrophoretically run. All CD1a mAb except OKT6 immunoprecipitated an additional molecule with an apparent relative mass of 27,000, under reducing conditions. CD1a antigen (Mr 49,000) was borne by the same chain of Mr 49,000 on cortical thymocytes and Langerhans cells, whereas the Mr 27,000 molecule was never found on thymic cells. On two-dimensional gel analysis, the Mr 27,000 molecule showed a pattern with 3 major spots with pI of 5.6, 5.9 and 6.2. This Mr 27,000 protein was found to contain one N-linked oligosaccharide residue by endoglycosidase-F treatment. By sequential immunoprecipitation, this Mr 27,000 molecule was shown to be different from the major histocompatibility complex class II beta-chains (DR, DP). As the Mr 27,000 molecule was not precipitated with OKT6, sequential immunoprecipitation confirmed specific recognition of this low molecular weight protein by other CD1a mAb. The protein of apparent molecular mass 27,000 was considered to be a breakdown product of Mr 49,000 (CD1a) antigen. These results suggested that the CD1a molecule was sensitive to trypsin.
 ...
PMID:Cleavage of Langerhans cell surface CD1a molecule by trypsin. 247 41